Prevalence of homologous recombination biomarkers in multiple tumor types: an observational study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE2013 · 939 citations
2. 2Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma2021 · 12 citations
3. 3PARP Inhibitor Insensitivity to <i>BRCA1/2</i> Monoallelic Mutations in Microsatellite Instability-High Cancers2022 · 42 citations
4. 4Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort2022 · 56 citations
5. 5RETRACTED: Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types2021 · 16 citations